We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-18.45%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$122M
AUM Growth
+$7.43M
Cap. Flow
+$13.4M
Cap. Flow %
10.99%
Top 10 Hldgs %
82.45%
Holding
116
New
28
Increased
22
Reduced
30
Closed
27

Sector Composition

Rank Sector Weight
1 Healthcare 14.59%
2 Consumer Discretionary 2%
3 Industrials 1.44%
4 Financials 1.38%
5 Communication Services 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUDI icon
101
Huadi International Group
HUDI
$10.8M
-169,198
Closed -$528K
INBS icon
102
Intelligent Bio Solutions
INBS
$3.81M
-1,055
Closed -$367K
NCRA icon
103
Nocera
NCRA
$2.23M
-2,114
Closed -$74.3K
ONFO icon
104
Onfolio Holdings
ONFO
$808K
-90,210
Closed -$144K
HIND
105
Vyome Holdings
HIND
$14M
-13
Closed -$192K
RVPH
106
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
-1,431
Closed -$181K
TANH icon
107
Tantech Holdings
TANH
$6.15M
-596
Closed -$45.8K
DVLT
108
Datavault AI
DVLT
$281M
-776
Closed -$181K
MMAT
109
DELISTED
Meta Materials Inc. Common Stock
MMAT
-1,603
Closed -$65.3K
MMAT
110
PUT
DELISTED
Meta Materials Inc. Common Stock
MMAT
-67
Closed -$273K
BRSH
111
DELISTED
Bruush Oral Care Inc. Common Stock
BRSH
-12,630
Closed -$82.1K
ARDS
112
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
-2,140,174
Closed -$672K
BIOC
113
DELISTED
Biocept, Inc.
BIOC
-987
Closed -$10.1K
APDNW
114
CALL
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
-244
Closed -$27.6K
APDNW
115
PUT
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
-885
Closed -$100K

Similar funds

Sabby Management's Q2 2023 Portfolio in Review

As of Q2 2023, Sabby Management held 116 positions worth $122M, up 6.5% from $115M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Sabby Management deployed $13.4M of net new capital in Q2 2023, opening 28 new positions and adding to 22 existing holdings. Its largest new stake was BRAINSTORM CELL THERAPUTC: 84,525 shares worth $2.61M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 9.8% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was CN Energy Group, an estimated $799K trimmed.

  • Sabby Management's largest Q2 2023 buy was BRAINSTORM CELL THERAPUTC: 84,525 shares worth $2.61M.
  • Sabby Management added most to Panbela Therapeutics, Inc. Common Stock in Q2 2023, an estimated $2.24M increase.
  • Sabby Management's biggest Q2 2023 reduction was CN Energy Group, cutting an estimated $799K.
  • Sabby Management fully exited AppTech Payments in Q2 2023, selling an estimated $1.03M.
  • Sabby Management's ten largest holdings make up 82% of its $122M portfolio in Q2 2023.
  • Sabby Management opened 28 new positions and closed 27 in Q2 2023.
  • Sabby Management's portfolio value rose 6.5% quarter-over-quarter to $122M.

Based on Sabby Management's 13F filing for Q2 2023, filed 14 Aug 2023.